| 27.86 1.65 (6.3%) | 01-15 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 35.9 | 1-year : | 40.71 |
| Resists | First : | 30.73 | Second : | 34.86 |
| Pivot price | 26.51 |
|||
| Supports | First : | 24.06 | Second : | 20.02 |
| MAs | MA(5) : | 26.22 |
MA(20) : | 27.05  |
| MA(100) : | 22.51 |
MA(250) : | 18.43 |
|
| MACD | MACD : | -0.4 |
Signal : | -0.4 |
| %K %D | K(14,3) : | 41.9 |
D(3) : | 30.3 |
| RSI | RSI(14): 52.7 |
|||
| 52-week | High : | 35.02 | Low : | 8.14 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ HIMS ] has closed below upper band by 22.4%. Bollinger Bands are 32.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 27.99 - 28.1 | 28.1 - 28.22 |
| Low: | 25.68 - 25.79 | 25.79 - 25.9 |
| Close: | 27.67 - 27.87 | 27.87 - 28.08 |
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
Wed, 15 Jan 2025
(HIMS) Long Term Investment Analysis - Stock Traders Daily
Wed, 15 Jan 2025
Investors in Hims & Hers Health (NYSE:HIMS) have seen enviable returns of 440% over the past three years - Yahoo Finance
Tue, 14 Jan 2025
Hims & Hers stock up as Eli Lilly GLP-1 sales miss (LLY:NYSE) - Seeking Alpha
Mon, 13 Jan 2025
Hims & Hers Health Options Trading: A Deep Dive into Market Sentiment - Benzinga
Tue, 07 Jan 2025
Hims & Hers donates $1 million to Trump's inauguration fund - CNBC
Tue, 07 Jan 2025
Hims donates to Trump's inaugural committee - Axios
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Household & Personal Products
|
|
| Shares Out | 210 (M) |
| Shares Float | 189 (M) |
| Held by Insiders | 11.4 (%) |
| Held by Institutions | 64.3 (%) |
| Shares Short | 42,970 (K) |
| Shares Short P.Month | 39,520 (K) |
| EPS | 0.43 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.01 |
| Profit Margin | 8.1 % |
| Operating Margin | 5.5 % |
| Return on Assets (ttm) | 5.6 % |
| Return on Equity (ttm) | 26.3 % |
| Qtrly Rev. Growth | 77 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 5.9 |
| EBITDA (p.s.) | 0.28 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 187 (M) |
| Levered Free Cash Flow | 127 (M) |
| PE Ratio | 63.31 |
| PEG Ratio | 0 |
| Price to Book value | 13.79 |
| Price to Sales | 4.72 |
| Price to Cash Flow | 31.35 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|